Neuronal FGF13 Inhibits Mitochondria‐Derived Damage Signals to Prevent Neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson's Disease
Abstract Fibroblast growth factor homologous factors (FHFs) are highly expressed in the central nervous system (CNS). It is demonstrated that the FHFs subfamily plays cardinal roles in several neuropathological diseases, while their involvement in Parkinson's disease (PD) has been so far scarce...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-07-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202503579 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839617824722518016 |
---|---|
author | Nanshan Song Xiangxu Wang Luqing Ha Lamei Hu Shuyuan Mei Yue Liang Yujie Zhao Xingyin Yang Qingyu Zhang Yuanzhang Zhou Jianhua Ding Yan Liu Qigang Zhou Feng Han Gang Hu Ming Lu |
author_facet | Nanshan Song Xiangxu Wang Luqing Ha Lamei Hu Shuyuan Mei Yue Liang Yujie Zhao Xingyin Yang Qingyu Zhang Yuanzhang Zhou Jianhua Ding Yan Liu Qigang Zhou Feng Han Gang Hu Ming Lu |
author_sort | Nanshan Song |
collection | DOAJ |
description | Abstract Fibroblast growth factor homologous factors (FHFs) are highly expressed in the central nervous system (CNS). It is demonstrated that the FHFs subfamily plays cardinal roles in several neuropathological diseases, while their involvement in Parkinson's disease (PD) has been so far scarcely investigated. From the publicly available Gene Expression Omnibus (GEO) datasets, FHF2 (also known as fibroblast growth factor 13, FGF13) alterations are described in PD patients. Fgf13 gene is significantly decreased in several PD mouse models, and its overexpression alleviates the PD‐like pathological phenotype. Although FGF13 is highly expressed in neurons, it functions by preventing glia‐dependent inflammatory processes. Mechanistically, FGF13 combines mitochondrial proteins such as MCHT2 (a protein localized on the mitochondrial outer membrane), to anchor mitochondria within the cytoplasm. Under PD‐related stress, decreased neuronal FGF13 levels induce the release of the damaged mitochondria, which in turn activate microglia and astrocytes, thereby promoting neurodegeneration. Abacavir, an FDA‐applied anti‐retroviral drug, is identified to prevent excessive gliosis and neuron loss in both glia‐neuron co‐cultures and PD mouse models by rejuvenating FGF13 signaling. Collectively, neuronal FGF13 inhibits the transfer of stressed mitochondria to glia, thereby impeding neuroinflammation and neurodegeneration. Abacavir is a promising neuroprotectant and sets a brake to PD progression. |
format | Article |
id | doaj-art-09c69f78fe714fd9a27b618bf2d8f34b |
institution | Matheson Library |
issn | 2198-3844 |
language | English |
publishDate | 2025-07-01 |
publisher | Wiley |
record_format | Article |
series | Advanced Science |
spelling | doaj-art-09c69f78fe714fd9a27b618bf2d8f34b2025-07-24T12:06:19ZengWileyAdvanced Science2198-38442025-07-011228n/an/a10.1002/advs.202503579Neuronal FGF13 Inhibits Mitochondria‐Derived Damage Signals to Prevent Neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson's DiseaseNanshan Song0Xiangxu Wang1Luqing Ha2Lamei Hu3Shuyuan Mei4Yue Liang5Yujie Zhao6Xingyin Yang7Qingyu Zhang8Yuanzhang Zhou9Jianhua Ding10Yan Liu11Qigang Zhou12Feng Han13Gang Hu14Ming Lu15School of Medicine Nanjing University of Chinese Medicine Nanjing 210023 ChinaJiangsu Key Laboratory of Neurodegeneration Department of Pharmacology Nanjing Medical University Nanjing 211166 ChinaSchool of Pharmacy Nanjing University of Chinese Medicine Nanjing 210023 ChinaJiangsu Key Laboratory of Neurodegeneration Department of Pharmacology Nanjing Medical University Nanjing 211166 ChinaThe Clinical Medical College Nanjing Medical University Nanjing 211166 ChinaJiangsu Key Laboratory of Neurodegeneration Department of Pharmacology Nanjing Medical University Nanjing 211166 ChinaJiangsu Key Laboratory of Neurodegeneration Department of Pharmacology Nanjing Medical University Nanjing 211166 ChinaThe Clinical Medical College Nanjing Medical University Nanjing 211166 ChinaSchool of Medicine Nanjing University of Chinese Medicine Nanjing 210023 ChinaSchool of Medicine Nanjing University of Chinese Medicine Nanjing 210023 ChinaJiangsu Key Laboratory of Neurodegeneration Department of Pharmacology Nanjing Medical University Nanjing 211166 ChinaJiangsu Key Laboratory of Neurodegeneration Department of Pharmacology Nanjing Medical University Nanjing 211166 ChinaJiangsu Key Laboratory of Neurodegeneration Department of Pharmacology Nanjing Medical University Nanjing 211166 ChinaJiangsu Key Laboratory of Neurodegeneration Department of Pharmacology Nanjing Medical University Nanjing 211166 ChinaSchool of Medicine Nanjing University of Chinese Medicine Nanjing 210023 ChinaJiangsu Key Laboratory of Neurodegeneration Department of Pharmacology Nanjing Medical University Nanjing 211166 ChinaAbstract Fibroblast growth factor homologous factors (FHFs) are highly expressed in the central nervous system (CNS). It is demonstrated that the FHFs subfamily plays cardinal roles in several neuropathological diseases, while their involvement in Parkinson's disease (PD) has been so far scarcely investigated. From the publicly available Gene Expression Omnibus (GEO) datasets, FHF2 (also known as fibroblast growth factor 13, FGF13) alterations are described in PD patients. Fgf13 gene is significantly decreased in several PD mouse models, and its overexpression alleviates the PD‐like pathological phenotype. Although FGF13 is highly expressed in neurons, it functions by preventing glia‐dependent inflammatory processes. Mechanistically, FGF13 combines mitochondrial proteins such as MCHT2 (a protein localized on the mitochondrial outer membrane), to anchor mitochondria within the cytoplasm. Under PD‐related stress, decreased neuronal FGF13 levels induce the release of the damaged mitochondria, which in turn activate microglia and astrocytes, thereby promoting neurodegeneration. Abacavir, an FDA‐applied anti‐retroviral drug, is identified to prevent excessive gliosis and neuron loss in both glia‐neuron co‐cultures and PD mouse models by rejuvenating FGF13 signaling. Collectively, neuronal FGF13 inhibits the transfer of stressed mitochondria to glia, thereby impeding neuroinflammation and neurodegeneration. Abacavir is a promising neuroprotectant and sets a brake to PD progression.https://doi.org/10.1002/advs.202503579FGF13mitochondrial transferMTCH2neuroinflammationparkinson's disease |
spellingShingle | Nanshan Song Xiangxu Wang Luqing Ha Lamei Hu Shuyuan Mei Yue Liang Yujie Zhao Xingyin Yang Qingyu Zhang Yuanzhang Zhou Jianhua Ding Yan Liu Qigang Zhou Feng Han Gang Hu Ming Lu Neuronal FGF13 Inhibits Mitochondria‐Derived Damage Signals to Prevent Neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson's Disease Advanced Science FGF13 mitochondrial transfer MTCH2 neuroinflammation parkinson's disease |
title | Neuronal FGF13 Inhibits Mitochondria‐Derived Damage Signals to Prevent Neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson's Disease |
title_full | Neuronal FGF13 Inhibits Mitochondria‐Derived Damage Signals to Prevent Neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson's Disease |
title_fullStr | Neuronal FGF13 Inhibits Mitochondria‐Derived Damage Signals to Prevent Neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson's Disease |
title_full_unstemmed | Neuronal FGF13 Inhibits Mitochondria‐Derived Damage Signals to Prevent Neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson's Disease |
title_short | Neuronal FGF13 Inhibits Mitochondria‐Derived Damage Signals to Prevent Neuroinflammation and Neurodegeneration in a Mouse Model of Parkinson's Disease |
title_sort | neuronal fgf13 inhibits mitochondria derived damage signals to prevent neuroinflammation and neurodegeneration in a mouse model of parkinson s disease |
topic | FGF13 mitochondrial transfer MTCH2 neuroinflammation parkinson's disease |
url | https://doi.org/10.1002/advs.202503579 |
work_keys_str_mv | AT nanshansong neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT xiangxuwang neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT luqingha neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT lameihu neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT shuyuanmei neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT yueliang neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT yujiezhao neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT xingyinyang neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT qingyuzhang neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT yuanzhangzhou neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT jianhuading neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT yanliu neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT qigangzhou neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT fenghan neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT ganghu neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease AT minglu neuronalfgf13inhibitsmitochondriaderiveddamagesignalstopreventneuroinflammationandneurodegenerationinamousemodelofparkinsonsdisease |